Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014

ON Helix

02 Jul 2014 - 02 Jul 2014 - Cambridge, UK

Bookmark and Share

The ‘ON Helix’ translational research conference will bring together key experts from industry and academia to discuss how we can help ground-breaking primary research successfully transition into treatments for patients.

The topics covered during this one day event will centre around:

  • The UK business environment 
  • Research funding
  • Scientific and clinical research excellence 
  • How ideas and early stage inventions are turned into innovative health treatments 

The high profile global leaders that will give presentations and/or join in as part of panel discussions include:

  • Dr. Mene Pangalos, Executive Vice president Innovative Medicines and Early Research at AstraZeneca
  • Sir Mike Rawlins, Chairman of the EAHSN and President of the Royal Society of Medicine
  • Sir Gregory Winter, Master, Trinity College, Cambridge and founder of Bicycle Therapeutics Ltd
  • Rob Pinnock, Director Scientific Liaison, UK, Ireland, Portugal and Spain, Merck Sharp & Dohme 
  • Hermann Hauser, serial Cambridge entrepreneur and venture capitalist 
  • and other highly regarded and respected personalities form industry and academia

 This event is aimed at:

  • Biotech and healthcare company, senior executives
  • Academic technology transfer executives
  • Pharma business and research development directors
  • Life science investors
  • Technical and professional service providers

At the end of the talk and panel discussions, there will be a drinks reception and plenty of time for networking and partnering.

Further information
Scientific News
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Potential Target for Treatment of Autism
Grant of $2.4 million will support further research.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Molecular ‘Kiss Of Death’ Flags Pathogens For Destruction
Researchers have discovered that our bodies mark pathogen-containing vacuoles for destruction by using a molecule called ubiquitin, commonly known as the "kiss of death."
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Milestone Single-Biomolecule Imaging Technique May Advance Drug Design
The first nanometer resolved image of individual tobacco mosaic virions shows the potential of low-energy electron holography for imaging biomolecules at a single particle level; a milestone in structural biology and a potential new tool for drug design.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos